US Bancorp DE Makes New $96,000 Investment in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

US Bancorp DE purchased a new position in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 2,224 shares of the company’s stock, valued at approximately $96,000.

Several other hedge funds also recently modified their holdings of XPH. BNP Paribas Financial Markets boosted its stake in shares of SPDR S&P Pharmaceuticals ETF by 208.6% during the 3rd quarter. BNP Paribas Financial Markets now owns 149,419 shares of the company’s stock worth $6,628,000 after purchasing an additional 101,000 shares during the last quarter. Stifel Financial Corp acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF in the third quarter worth approximately $337,000. JPMorgan Chase & Co. boosted its position in shares of SPDR S&P Pharmaceuticals ETF by 36.2% in the third quarter. JPMorgan Chase & Co. now owns 4,443 shares of the company’s stock worth $197,000 after acquiring an additional 1,182 shares during the last quarter. CX Institutional acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF in the fourth quarter worth approximately $438,000. Finally, AlphaMark Advisors LLC boosted its position in shares of SPDR S&P Pharmaceuticals ETF by 6.7% in the fourth quarter. AlphaMark Advisors LLC now owns 6,640 shares of the company’s stock worth $285,000 after acquiring an additional 415 shares during the last quarter.

SPDR S&P Pharmaceuticals ETF Stock Performance

XPH opened at $42.95 on Monday. The company’s 50 day simple moving average is $44.30 and its 200 day simple moving average is $44.77. SPDR S&P Pharmaceuticals ETF has a 1 year low of $38.88 and a 1 year high of $48.76. The stock has a market capitalization of $154.62 million, a PE ratio of 15.01 and a beta of 0.72.

SPDR S&P Pharmaceuticals ETF Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.